Entegris
129 Concord Road, Billerica, MA, 01821, United States
Overview
Entegris, Inc. (NASDAQ: ENTG) is a leading supplier of advanced materials and process solutions for the semiconductor, life sciences, and other high-tech industries. For over 50 years, we have been committed to solving our customers’ most demanding process challenges through a broad solutions portfolio, collaborative and innovative product development, and a focus on science and applications knowledge. Entegris has approximately 8,000 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. Our highly skilled team members, facilities, and resources are right where you need them to help you solve your most advanced technology challenges. Additional information can be found at www.entegris.com.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 8
Sector focus
- Advanced Materials
- Chemical
- Data Storage
- Manufacturing
- Semiconductor
Investment portfolio
- TeraPore Technologies
Participated · Equity · Mar 2023
TeraPore Technologies develops high-permeability, high-resolution membrane nanofiltration systems for bioprocessing, centered on its Intelligent Membrane platform. Its technology features a tunable chemical structure and uniform nanoscale pore sizes designed to address difficult bioseparation challenges. The company is launching its IsoBlock™ virus filter family, engineered for high productivity and robust viral clearance across development, clinical trials, and production. TeraPore aims to expand the use of its core technology into new high-value markets and contamination-control applications. The company is venture-backed and has received grant funding from NSF, NIH, and the Defense Threat Reduction Agency. It will use the new financing to commercialize IsoBlock filters and broaden market deployment. TeraPore Technologies develops and manufactures advanced nanofiltration membrane systems using a proprietary block copolymer self-assembly technology. The polymers spontaneously form highly uniform structures that create precise nanoscale pores when fabricated into membranes. Its membranes target critical bioprocess applications, notably the separation of viral contaminants in biologics production. The company is led by founder and CEO Dr. Rachel Dorin and was founded in 2013 as a Cornell University spinout. TeraPore is based in South San Francisco, CA, and has received support from the NIH, NSF and DTRA. It intends to use the Series A proceeds to accelerate product development and commercialization efforts.